Al Kraus - 06 Feb 2023 Form 4 Insider Report for Cytosorbents Corp (CTSO)

Role
Director
Signature
/s/ Kathleen P. Bloch attorney-in-fact for Al Kraus
Issuer symbol
CTSO
Transactions as of
06 Feb 2023
Net transactions value
+$31,800
Form type
4
Filing time
08 Feb 2023, 05:03:33 UTC
Previous filing
12 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTSO Common Stock Options Exercise $31,800 +12,000 +9.2% $2.65 142,046 06 Feb 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTSO Stock Option (right to buy) Options Exercise $0 -12,000 -100% $0.000000* 0 06 Feb 2023 Common Stock 12,000 $2.65 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes: (i) the following RSUs that will be settled into common stock upon vesting upon a "Change In Control" of CytoSorbents Corporation (the "Company") as defined in the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan: (a) 55,000 RSUs granted on April 8, 2015, (b) 5,000 RSUs granted on June 7, 2016, (c) 6,000 RSUs granted on February 24, 2017 and (d) 3,300 RSUs granted on March 15, 2018; and (ii) 72,746 shares of common stock owned by the reporting person.
F2 The stock options were granted to the reporting person on February 6, 2013 and were exercisable on the date of grant.